Advertisement
NPJ Precision Oncology Impact Factor: A Deep Dive into Journal Metrics and Significance
Introduction:
Are you a researcher navigating the complex world of scientific publishing? Understanding the impact factor of a journal is crucial for choosing where to submit your groundbreaking work in precision oncology. This comprehensive guide delves into the NPJ Precision Oncology impact factor, exploring its meaning, trends, calculation, and implications for your research career. We'll unpack the significance of this metric, offering insights into how it influences journal selection, funding applications, and overall career trajectory within the field. This isn't just a simple number; it's a reflection of the journal's influence and the potential impact your publication can have.
1. Understanding the NPJ Precision Oncology Impact Factor:
The impact factor (IF) is a crucial metric reflecting the average number of citations received by articles published in a journal during a specific period (typically the preceding two years). A higher impact factor generally indicates greater influence and visibility within the scientific community. NPJ Precision Oncology, published by Nature Portfolio, is a leading journal in its field, and its impact factor reflects the high quality and relevance of the research it publishes. However, it's vital to remember that the impact factor is just one metric among many, and shouldn't be the sole determinant for journal selection.
2. Factors Influencing the NPJ Precision Oncology Impact Factor:
Several factors contribute to a journal's impact factor, including:
Article Quality: Rigorous peer review processes ensure only high-quality, impactful research is published. NPJ Precision Oncology adheres to strict standards, resulting in publications that are frequently cited.
Journal Reputation and Prestige: As a Nature Portfolio journal, NPJ Precision Oncology benefits from the established reputation and trust associated with the Nature brand. This inherent prestige attracts high-quality submissions and increases the likelihood of citations.
Citation Practices within the Field: Citation behavior within precision oncology influences the impact factor. A field with a high rate of citation naturally leads to higher impact factors for journals within that field.
Journal Scope and Focus: A clearly defined scope allows for targeted readership and higher citation rates from researchers specifically working within that niche. The focus of NPJ Precision Oncology on precision oncology ensures that its articles are highly relevant to a focused audience.
Open Access Policy: NPJ Precision Oncology's open-access policy enhances article visibility and accessibility, potentially leading to increased citations. Wider dissemination contributes significantly to a journal's impact factor.
3. Trends in the NPJ Precision Oncology Impact Factor:
Analyzing the trend of the NPJ Precision Oncology impact factor over time provides valuable insights. While specific numbers fluctuate year to year, a general upward trend indicates a growing influence and recognition within the scientific community. This information can be found on databases like Journal Citation Reports (JCR). Monitoring these trends helps researchers understand the journal's trajectory and its position relative to competitors.
4. Interpreting the NPJ Precision Oncology Impact Factor:
It's crucial to interpret the impact factor within its context. A high impact factor doesn't automatically guarantee the quality of individual articles. Researchers should carefully evaluate the relevance of the journal to their specific research area and the overall quality of published work before submitting their manuscripts. The impact factor is a helpful indicator, but not the sole criterion for publication decisions.
5. The Importance of the Impact Factor for Researchers:
The impact factor plays a vital role in several aspects of a researcher's career:
Grant Applications: Funding agencies often consider the impact factor of the journals where researchers have published their work. A higher impact factor can strengthen a grant application.
Job Applications and Promotions: Impact factor is a frequently used metric in assessing the productivity and impact of researchers. Publishing in high-impact journals can enhance job prospects and career advancement.
Career Recognition and Visibility: Publications in journals with high impact factors increase a researcher's visibility and reputation within the scientific community.
6. Beyond the Impact Factor: Other Journal Metrics:
While the impact factor is a significant metric, researchers should also consider other factors when evaluating journals, including:
Article-level metrics: These metrics provide insights into the individual performance of articles, such as downloads, altmetrics, and social media engagement.
Journal audience and readership: Understanding the readership base of a journal allows researchers to target their work to the most relevant audience.
Editorial board expertise: A strong editorial board composed of leading researchers enhances the quality and credibility of the journal.
Publication speed: Efficient processing times are crucial for timely dissemination of research findings.
7. Strategic Implications for Authors:
Selecting the right journal is a crucial step in the publication process. Carefully consider the impact factor, journal scope, and other relevant metrics to ensure that your work reaches the widest possible audience. Choosing a journal aligned with your research's focus is crucial for maximizing its impact.
Article Outline: NPJ Precision Oncology Impact Factor: A Comprehensive Guide
I. Introduction:
Hook: Importance of impact factor for researchers in precision oncology
Overview of the article's content
II. Understanding the NPJ Precision Oncology Impact Factor:
Definition and calculation of impact factor
Significance in precision oncology research
III. Factors Influencing the Impact Factor:
Article quality, peer review
Journal reputation and prestige
Citation practices, journal scope
Open access policies
IV. Trends in the Impact Factor:
Analyzing historical data and predicting future trends
Comparing with similar journals
V. Interpreting the Impact Factor:
Cautions and limitations of using impact factor alone
Importance of holistic journal evaluation
VI. The Importance of Impact Factor for Researchers:
Grant applications, job prospects, career advancement
VII. Beyond the Impact Factor:
Alternative metrics (e.g., altmetrics)
Journal audience and readership, editorial board expertise
VIII. Strategic Implications for Authors:
Choosing the right journal for maximizing impact
IX. Conclusion:
Summary of key points and recommendations
(Detailed explanation of each point is provided above in the main article body.)
FAQs:
1. What is the current impact factor of NPJ Precision Oncology? The current impact factor can be found on the Journal Citation Reports (JCR) website. It fluctuates yearly, so checking the most recent data is crucial.
2. How is the impact factor calculated? It's calculated by dividing the number of citations received by articles published in the journal during the past two years by the total number of citable articles published in those two years.
3. Is a high impact factor always indicative of high-quality research? No. While a high impact factor suggests significant influence, it doesn't guarantee the quality of individual articles.
4. Should I only consider the impact factor when selecting a journal? No. Consider factors like journal scope, readership, and editorial board alongside the impact factor.
5. How does the impact factor affect grant applications? Many funding agencies consider impact factor as a metric of research quality and impact, so it can strengthen grant proposals.
6. Does the impact factor influence job prospects? Yes, it often plays a role in evaluating a researcher's productivity and impact.
7. What are altmetrics? Altmetrics are alternative metrics that measure the online impact of research beyond traditional citations, such as social media shares and downloads.
8. How often is the impact factor updated? The impact factor is typically updated annually by Clarivate Analytics.
9. Where can I find the impact factor of NPJ Precision Oncology? Check the Journal Citation Reports (JCR) database or the official journal website.
Related Articles:
1. Understanding Journal Impact Factors: A Guide for Researchers: An overview of impact factors and their implications for researchers.
2. Choosing the Right Journal for Your Research: A guide to selecting the best journal for your manuscript.
3. The Role of Altmetrics in Research Evaluation: A discussion on the use of alternative metrics in assessing research impact.
4. Open Access Publishing and its Impact on Research Dissemination: An exploration of open access publishing and its advantages.
5. The Peer Review Process: Ensuring Research Quality: Details on the peer review process and its importance.
6. How to Write a Compelling Research Paper: A guide to writing a high-quality research manuscript.
7. Grant Writing Strategies for Success: Tips and strategies for writing successful grant proposals.
8. Navigating the Academic Job Market: Advice for researchers seeking academic positions.
9. Precision Oncology: Advances and Challenges: A review of recent advances and challenges in precision oncology.
npj precision oncology impact factor: Precision Medicine in Oncology Bulent Aydogan, James A. Radosevich, 2020-11-02 A FRESH EXAMINATION OF PRECISION MEDICINE'S INCREASINGLY PROMINENT ROLE IN THE FIELD OF ONCOLOGY Precision medicine takes into account each patient's specific characteristics and requirements to arrive at treatment plans that are optimized towards the best possible outcome. As the field of oncology continues to advance, this tailored approach is becoming more and more prevalent, channelling data on genomics, proteomics, metabolomics and other areas into new and innovative methods of practice. Precision Medicine in Oncology draws together the essential research driving the field forward, providing oncology clinicians and trainees alike with an illuminating overview of the technology and thinking behind the breakthroughs currently being made. Topics covered include: Biologically-guided radiation therapy Informatics for precision medicine Molecular imaging Biomarkers for treatment assessment Big data Nanoplatforms Casting a spotlight on this emerging knowledge base and its impact upon the management of tumors, Precision Medicine in Oncology opens up new possibilities and ways of working not only for oncologists, but also for molecular biologists, radiologists, medical geneticists, and others. |
npj precision oncology impact factor: Precision Medicine in Cancer Therapy Daniel D. Von Hoff, Haiyong Han, 2019-06-17 This book presents the latest advances in precision medicine in some of the most common cancer types, including hematological, lung and breast malignancies. It also discusses emerging technologies that are making a significant impact on precision medicine in cancer therapy. In addition to describing specific approaches that have already entered clinical practice, the book explores new concepts and tools that are being developed. Precision medicine aims to deliver personalized healthcare tailored to a patient’s genetics, lifestyle and environment, and cancer therapy is one of the areas in which it has flourished in recent years. Documenting the latest advances, this book is of interest to physicians and clinical fellows in the front line of the war on cancer, as well as to basic scientists working in the fields of cancer biology, drug development, biomarker discovery, and biomedical engineering. The contributing authors include translational physicians with first-hand experience in precision patient care. |
npj precision oncology impact factor: Gaps and Actions in Health Improvement from Hong Kong and Beyond Ben Yuk Fai Fong, William Chi Wai Wong, 2023-10-15 This book provides a timely review on what has been accomplished, and what remains amiss, following the World Health Organization’s 1978 ‘Health for All’ campaign, by identifying enduring gaps in health care within a global context. The WHO declaration of Health for All by the Year 2000 mapped out a road towards primary health care for all people and demarcated it as essential for human progress in terms of economic development and social justice. However, 45 years have gone by, and most societies and countries have yet achieved 'health for all’, despite so much having changed in technology, disease patterns, and population demographics. In promoting community health and improving service delivery, the book advocates the development and implementation of “All For Health” strategies to steer stakeholders in the right direction towards universal health care. The book covers the gaps and actions in health improvements, the ‘All For Health’ strategies, and the Health in All Policies (HiAP), reviewing and discussing issues through both Asian and international examples. Contributors include both academics and practitioners from diverse professional backgrounds including medicine, nursing, pharmacy, allied health, dietetics, social sciences, life sciences, education, business, administration, law, and public policy. Essential to scholars in public health and related disciplines, this book is also useful to policymakers, community and public health practitioners, and health care executives and interns. |
npj precision oncology impact factor: Encyclopedia of Biomedical Gerontology , 2019-11-20 Encyclopedia of Biomedical Gerontology, Three Volume Set presents a wide range of topics, ranging from what happens in the body during aging, the reasons and mechanisms relating to those age-related changes, and their clinical, psychological and social modulators and determinants. The book covers the biological and medical aspects of gerontology within the general framework of the biological basis of assessing age, biological mechanisms of aging, age-related changes in biological systems, human age-related diseases, the biomedical practicality and impracticality of interventions, and finally, the ethics of intervention. Provides a ‘one-stop’ resource to information written by world-leading scholars in the field of biomedical gerontology Fills a critical gap of information in a field that has seen significant progress in the last 10 years |
npj precision oncology impact factor: Clinical PET/MRI Onofrio Antonio Catalano, 2022-09-07 Clinical PET/MR presents the state-of-the-art of PET/MR, guiding the reader from how to scan patients, how to read and report the studies, and how keep an eye on what is clinically relevant for a patient's care. Each chapter starts with the clinical scenario and then moves to pertinent imaging, addressing the need of a clinical PET/MR book written by world experts in both clinical and imaging fields. It discusses the clinical application of PET/MR in diverse subspecialties such as head and neck, neurology, cardiovascular, pediatrics, chest, bone, hematology, breast, hepatobiliary pancreatic, genitourinary, gynecology, and gastrointestinal tract. This book is a valuable resource for radiologists, oncologists and members of the biomedical field who need to learn more about clinical applications of PET/MR. - Presents a description of robust acquisition protocols to teach readers how to scan PET/MR patients, from tracers to sequences - Provides a clinical background section in each chapter to help readers focus on the real clinical issues that need to be addressed in the medical report - Written by world authorities in the field in a didactic manner to describe the real status of imaging |
npj precision oncology impact factor: NMR-based Metabolomics Hector C Keun, 2018-01-17 This book describes the state of the art in the application of NMR spectroscopy to metabolomics and will be a key title for researchers and practitioners. |
npj precision oncology impact factor: Artificial Intelligence in Behavioral and Mental Health Care David D. Luxton, 2015-09-10 Artificial Intelligence in Behavioral and Mental Health Care summarizes recent advances in artificial intelligence as it applies to mental health clinical practice. Each chapter provides a technical description of the advance, review of application in clinical practice, and empirical data on clinical efficacy. In addition, each chapter includes a discussion of practical issues in clinical settings, ethical considerations, and limitations of use. The book encompasses AI based advances in decision-making, in assessment and treatment, in providing education to clients, robot assisted task completion, and the use of AI for research and data gathering. This book will be of use to mental health practitioners interested in learning about, or incorporating AI advances into their practice and for researchers interested in a comprehensive review of these advances in one source. - Summarizes AI advances for use in mental health practice - Includes advances in AI based decision-making and consultation - Describes AI applications for assessment and treatment - Details AI advances in robots for clinical settings - Provides empirical data on clinical efficacy - Explores practical issues of use in clinical settings |
npj precision oncology impact factor: Biosensors in Precision Medicine Laís Canniatti Brazaca, Juliane Renata Sempionatto, 2024-02-13 Biosensors in Precision Medicine: From Fundamentals to Future Trends covers important topics regarding biomarkers, including biomarker discovery, validation, application in precision medicine, the principles of biosensors, their use in precision medicine, important analytical parameters, recent advances in bioreceptors and transduction, and more. Finally, the hottest trends of biosensors in precision medicine, including lab-on-a-chip and wearable devices, advances towards telemedicine, machine learning, artificial intelligence and the commerciality of these devices are discussed. - Provides a timely review of the state-of-the-art developments in biosensors and their applications in precision medicine - Presents an evaluation of case studies, along with real-life examples - Addresses recent trends on biosensors for precision medicine |
npj precision oncology impact factor: Advancing Healthcare Through Personalized Medicine Priya Hays, 2021-09-27 This book provides a unique perspective on the biomedical and societal implications of personalized medicine and how it helps to mitigate the healthcare crisis and rein in ever-growing expenditure. It introduces the reader to the underlying concepts at the heart of personalized medicine. An innovative second edition, this book functions as an update to the successful first edition to include new, state-of-the-art information and advancements in the fast-paced field of personalized medicine. Chapters examine pharmacogenomics, targeted therapies, individualized diagnosis and treatment, and cancer immunotherapies. The book also features an essential discussion on how the advent of genomic technologies gives clinicians the capability to predict and diagnose disease more efficiently and offers a detailed up-to-date compilation of clinical trials in cancer leading to breakthrough therapies. The book also addresses the impact of Big Data on personalized medicine and the newfound applications of digital health and artificial intelligence. A work that advocates for a patient-centered approach, Advancing Healthcare Through Personalized Medicine, Second Edition is an invaluable text for clinicians, healthcare providers, and patients. |
npj precision oncology impact factor: 'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine Nosheen Masood, Saima Shakil Malik, 2020-03-20 This book concisely describes the role of omics in precision medicine for cancer therapies. It outlines our current understanding of cancer genomics, shares insights into the process of oncogenesis, and discusses emerging technologies and clinical applications of cancer genomics in prognosis and precision-medicine treatment strategies. It then elaborates on recent advances concerning transcriptomics and translational genomics in cancer diagnosis, clinical applications, and personalized medicine in oncology. Importantly, it also explains the importance of high-performance analytics, predictive modeling, and system biology in cancer research. Lastly, the book discusses current and potential future applications of pharmacogenomics in clinical cancer therapy and cancer drug development. |
npj precision oncology impact factor: Cancer diagnostics in solid tumors - from pathology to precision oncology Pedro Borralho, Fernando Schmitt, Liang Wang, Umberto Malapelle, 2023-04-05 |
npj precision oncology impact factor: Precision Medicine and Artificial Intelligence Michael Mahler, 2021-03-12 Precision Medicine and Artificial Intelligence: The Perfect Fit for Autoimmunity covers background on artificial intelligence (AI), its link to precision medicine (PM), and examples of AI in healthcare, especially autoimmunity. The book highlights future perspectives and potential directions as AI has gained significant attention during the past decade. Autoimmune diseases are complex and heterogeneous conditions, but exciting new developments and implementation tactics surrounding automated systems have enabled the generation of large datasets, making autoimmunity an ideal target for AI and precision medicine. More and more diagnostic products utilize AI, which is also starting to be supported by regulatory agencies such as the Food and Drug Administration (FDA). Knowledge generation by leveraging large datasets including demographic, environmental, clinical and biomarker data has the potential to not only impact the diagnosis of patients, but also disease prediction, prognosis and treatment options. - Allows the readers to gain an overview on precision medicine for autoimmune diseases leveraging AI solutions - Provides background, milestone and examples of precision medicine - Outlines the paradigm shift towards precision medicine driven by value-based systems - Discusses future applications of precision medicine research using AI - Other aspects covered in the book include regulatory insights, data analytics and visualization, types of biomarkers as well as the role of the patient in precision medicine |
npj precision oncology impact factor: Deep Learning for Cancer Diagnosis Utku Kose, Jafar Alzubi, 2020-09-12 This book explores various applications of deep learning to the diagnosis of cancer,while also outlining the future face of deep learning-assisted cancer diagnostics. As is commonly known, artificial intelligence has paved the way for countless new solutions in the field of medicine. In this context, deep learning is a recent and remarkable sub-field, which can effectively cope with huge amounts of data and deliver more accurate results. As a vital research area, medical diagnosis is among those in which deep learning-oriented solutions are often employed. Accordingly, the objective of this book is to highlight recent advanced applications of deep learning for diagnosing different types of cancer. The target audience includes scientists, experts, MSc and PhD students, postdocs, and anyone interested in the subjects discussed. The book can be used as a reference work to support courses on artificial intelligence, medical and biomedicaleducation. |
npj precision oncology impact factor: Huether and McCance's Understanding Pathophysiology, Canadian Edition - E-Book Kelly Power-Kean, Stephanie Zettel, Mohamed Toufic El-Hussein, Sue E. Huether, Kathryn L. McCance, 2022-01-08 **Textbook and Academic Authors Association (TAA) Textbook Excellence Award Winner, 2024** Prepare for Canadian nursing practice with a solid understanding of pathophysiology and disease! Huether and McCance's Understanding Pathophysiology, 2nd Canadian Edition covers the basic concepts of pathophysiology and disease processes from a Canadian perspective. Clear descriptions and vibrant illustrations make it easier to understand body systems and the mechanisms of disease, and online resources bring pathophysiology concepts to life. Developed for Canadian nursing students by educators Kelly Power-Kean, Stephanie Zettel, and Mohamed Toufic El-Hussein, this text prepares students for success on the Next Generation NCLEX®, CPNRE®, and REx-PNTM and also in clinical practice. - Introduction to Pathophysiology provides an entrance to the science of pathophysiology and explains why it is important. - Lifespan coverage includes nine separate chapters on developmental alterations in pathophysiology and special sections with aging and pediatrics content. - Canadian drug and treatment guidelines familiarize you with aspects of clinical practice you will encounter. - Coverage of diseases includes their pathophysiology, clinical manifestations, and evaluation and treatment. - Canadian lab values provide the core fundamental information required for practice in Canada. - Canadian morbidity statistics provide you with the Canadian context in which you will be practising. - Algorithms and flowcharts of diseases and disorders make it easy to follow the sequential progression of disease processes. - Health Promotion boxes emphasize evidence-based care and align with the Canadian curriculum. - Risk Factors boxes highlight important safety considerations associated with specific diseases. - Quick Check boxes test your understanding of important chapter concepts. - End-of-chapter Did You Understand? summaries make it easy to review the chapter's major concepts. - Key Terms are set in blue, boldface type and listed at the end of each chapter - Glossary of approximately 1,000 terms is included on the Evolve website with definitions of important terminology. |
npj precision oncology impact factor: Applying Big Data to Address the Social Determinants of Health in Oncology National Academies of Sciences, Engineering, and Medicine, Division on Engineering and Physical Sciences, Committee on Applied and Theoretical Statistics, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum, 2020-08-14 The National Academies of Sciences, Engineering, and Medicine held the workshop Applying Big Data to Address the Social Determinants of Health in Oncology on October 28â€29, 2019, in Washington, DC. This workshop examined social determinants of health (SDOH) in the context of cancer, and considered opportunities to effectively leverage big data to improve health equity and reduce disparities. The workshop featured presentations and discussion by experts in technology, oncology, and SDOH, as well as representatives from government, industry, academia, and health care systems. This publication summarizes the presentations and discussions from the workshop. |
npj precision oncology impact factor: Monoclonal Antibodies James W. Goding, 1986 This book represents the distillation and critical evaluation of many hundreds of publications relating to the production and use of antibodies. Therefore it is restricted to the core techniques of production and handling of antibodies, and their use in studies of antigen analysis, purification and localization. |
npj precision oncology impact factor: Translational Research in Breast Cancer Dong-Young Noh, Wonshik Han, Masakazu Toi, 2021-05-13 This book describes recent advances in translational research in breast cancer and presents emerging applications of this research that promise to have meaningful impacts on diagnosis and treatment. It introduces ideas and materials derived from the clinic that have been brought to the bench for basic research, as well as findings that have been applied back to the bedside. Detailed attention is devoted to breast cancer biology and cell signaling pathways and to cancer stem cell and tumor heterogeneity in breast cancer. Various patient-derived research models are discussed, and a further focus is the role of biomarkers in precision medicine for breast cancer patients. Next-generation clinical research receives detailed attention, addressing the increasingly important role of big data in breast cancer research and a wide range of other emerging developments. An entire section is also devoted to the management of women with high-risk breast cancer. Translational Research in Breast Cancer will help clinicians and scientists to optimize their collaboration in order to achieve the common goal of conquering breast cancer. |
npj precision oncology impact factor: Next Generation Sequencing Jerzy Kulski, 2016-01-14 Next generation sequencing (NGS) has surpassed the traditional Sanger sequencing method to become the main choice for large-scale, genome-wide sequencing studies with ultra-high-throughput production and a huge reduction in costs. The NGS technologies have had enormous impact on the studies of structural and functional genomics in all the life sciences. In this book, Next Generation Sequencing Advances, Applications and Challenges, the sixteen chapters written by experts cover various aspects of NGS including genomics, transcriptomics and methylomics, the sequencing platforms, and the bioinformatics challenges in processing and analysing huge amounts of sequencing data. Following an overview of the evolution of NGS in the brave new world of omics, the book examines the advances and challenges of NGS applications in basic and applied research on microorganisms, agricultural plants and humans. This book is of value to all who are interested in DNA sequencing and bioinformatics across all fields of the life sciences. |
npj precision oncology impact factor: Primary Central Nervous System Tumors Andrew D. Norden, David A. Reardon, Patrick C. Y. Wen, 2010-12-15 This comprehensive, yet practical, text is a ready collection of the most up-to-date information on primary CNS tumors. Authored by a carefully selected group of the world’s leading clinicians and scientists, the book is divided into three sections. The opening chapters cover general principles, including epidemiology, pathogenesis, tumor stem cells, supportive care, complications of therapy, and quality of life. The remaining two sections are comprised of treatment-oriented chapters covering the spectrum of gliomas and rarer tumor types. Each of these chapters presents multi-disciplinary therapeutic approaches and addresses specific disease concerns. Throughout, the authors incorporate the cutting-edge advances in molecular biology and genomics that are revolutionizing neuro-oncology. The result is an important clinical resource which provides evidence-based data and interpretation essential to intelligent therapeutic decision making. |
npj precision oncology impact factor: Human Genetics and Genomics Bruce R. Korf, Mira B. Irons, 2012-11-19 This fourth edition of the best-selling textbook, Human Genetics and Genomics, clearly explains the key principles needed by medical and health sciences students, from the basis of molecular genetics, to clinical applications used in the treatment of both rare and common conditions. A newly expanded Part 1, Basic Principles of Human Genetics, focuses on introducing the reader to key concepts such as Mendelian principles, DNA replication and gene expression. Part 2, Genetics and Genomics in Medical Practice, uses case scenarios to help you engage with current genetic practice. Now featuring full-color diagrams, Human Genetics and Genomics has been rigorously updated to reflect today’s genetics teaching, and includes updated discussion of genetic risk assessment, “single gene” disorders and therapeutics. Key learning features include: Clinical snapshots to help relate science to practice 'Hot topics' boxes that focus on the latest developments in testing, assessment and treatment 'Ethical issues' boxes to prompt further thought and discussion on the implications of genetic developments 'Sources of information' boxes to assist with the practicalities of clinical research and information provision Self-assessment review questions in each chapter Accompanied by the Wiley E-Text digital edition (included in the price of the book), Human Genetics and Genomics is also fully supported by a suite of online resources at www.korfgenetics.com, including: Factsheets on 100 genetic disorders, ideal for study and exam preparation Interactive Multiple Choice Questions (MCQs) with feedback on all answers Links to online resources for further study Figures from the book available as PowerPoint slides, ideal for teaching purposes The perfect companion to the genetics component of both problem-based learning and integrated medical courses, Human Genetics and Genomics presents the ideal balance between the bio-molecular basis of genetics and clinical cases, and provides an invaluable overview for anyone wishing to engage with this fast-moving discipline. |
npj precision oncology impact factor: Artificial Intelligence in Medical Imaging Erik R. Ranschaert, Sergey Morozov, Paul R. Algra, 2019-01-29 This book provides a thorough overview of the ongoing evolution in the application of artificial intelligence (AI) within healthcare and radiology, enabling readers to gain a deeper insight into the technological background of AI and the impacts of new and emerging technologies on medical imaging. After an introduction on game changers in radiology, such as deep learning technology, the technological evolution of AI in computing science and medical image computing is described, with explanation of basic principles and the types and subtypes of AI. Subsequent sections address the use of imaging biomarkers, the development and validation of AI applications, and various aspects and issues relating to the growing role of big data in radiology. Diverse real-life clinical applications of AI are then outlined for different body parts, demonstrating their ability to add value to daily radiology practices. The concluding section focuses on the impact of AI on radiology and the implications for radiologists, for example with respect to training. Written by radiologists and IT professionals, the book will be of high value for radiologists, medical/clinical physicists, IT specialists, and imaging informatics professionals. |
npj precision oncology impact factor: Tumor Organoids Shay Soker, Aleksander Skardal, 2017-10-20 Cancer cell biology research in general, and anti-cancer drug development specifically, still relies on standard cell culture techniques that place the cells in an unnatural environment. As a consequence, growing tumor cells in plastic dishes places a selective pressure that substantially alters their original molecular and phenotypic properties.The emerging field of regenerative medicine has developed bioengineered tissue platforms that can better mimic the structure and cellular heterogeneity of in vivo tissue, and are suitable for tumor bioengineering research. Microengineering technologies have resulted in advanced methods for creating and culturing 3-D human tissue. By encapsulating the respective cell type or combining several cell types to form tissues, these model organs can be viable for longer periods of time and are cultured to develop functional properties similar to native tissues. This approach recapitulates the dynamic role of cell–cell, cell–ECM, and mechanical interactions inside the tumor. Further incorporation of cells representative of the tumor stroma, such as endothelial cells (EC) and tumor fibroblasts, can mimic the in vivo tumor microenvironment. Collectively, bioengineered tumors create an important resource for the in vitro study of tumor growth in 3D including tumor biomechanics and the effects of anti-cancer drugs on 3D tumor tissue. These technologies have the potential to overcome current limitations to genetic and histological tumor classification and development of personalized therapies. |
npj precision oncology impact factor: Cancer Systems Biology Edwin Wang, 2010-05-04 The unprecedented amount of data produced with high-throughput experimentation forces biologists to employ mathematical representation and computation to glean meaningful information in systems-level biology. Applying this approach to the underlying molecular mechanisms of tumorgenesis, cancer research is enjoying a series of new discoveries and biological insights. Unique in its dualistic approach, this book introduces the concepts and theories of systems biology and their applications in cancer research. It presents basic cancer biology and cutting-edge topics of cancer research for computational biologists alongside systems biology analysis tools for experimental biologists. |
npj precision oncology impact factor: Reviews in Breast Cancer: 2023 Maria Rosaria De Miglio, Kevin Ni, Sulma Mohammed , Daniel P. Bezerra, 2024-10-25 Frontiers in Oncology is delighted to present the ‘Reviews in’ series of article collections. Reviews in Breast Cancer will publish high-quality review articles on key topics in the field. It aims to highlight recent advances in the field, whilst emphasizing important directions and new possibilities for future inquiries. The Reviews in Breast Cancer collection welcomes full-length, mini or systematic review papers. New articles will be added to this collection as they are published. |
npj precision oncology impact factor: Physical Activity and Cancer Kerry S. Courneya, Christine M. Friedenreich, 2010-11-26 This book explores in depth the relation between physical activity and cancer control, including primary prevention, coping with treatments, recovery after treatments, long-term survivorship, secondary prevention, and survival. The first part of the book presents the most recent research on the impact of physical activity in preventing a range of cancers. In the second part, the association between physical activity and cancer survivorship is addressed. The effects of physical activity on supportive care endpoints (e.g., quality of life, fatigue, physical functioning) and disease endpoints (e.g., biomarkers, recurrence, survival) are carefully analyzed. In addition, the determinants of physical activity in cancer survivors are discussed, and behavior change strategies for increasing physical activity in cancer survivors are appraised. The final part of the book is devoted to special topics, including the relation of physical activity to pediatric cancer survivorship and to palliative cancer care. |
npj precision oncology impact factor: Central Nervous System Metastases Rohan Ramakrishna, Rajiv S. Magge, Ali A. Baaj, Jonathan P.S. Knisely, 2020-05-27 This is a multi-specialty book on the diagnosis, evaluation, and treatment of CNS metastases of the brain and spine. Written by renowned experts in their fields, the book covers essential contemporary topics in CNS metastases care. The book is divided into seven parts that begin with chapters that cover the fundamental biology of disease so that subsequent chapters on imaging, diagnosis, treatment, and palliation can be properly contextualized. This text also provides a framework for understanding the biology of radiation therapy so that radiation treatment options of the brain and spine can be more fully understood. New medications and technologies are reviewed from the perspective of maximizing efficacy and minimizing toxicity, independently and as combinatorial therapy. Central Nervous System Metastases: Diagnosis and Treatment serves as a practical reference for health care providers and trainees. It provides the comprehensive, detailed perspective required to provide holistic care to patients with metastatic disease to the brain and spine. |
npj precision oncology impact factor: Essential Genetic and Genomic Competencies for Nurses with Graduate Degrees Karen E. Greco, Susan Tinley, Diane Seibert, 2012 Describes and delineates the thirty eight essential genetic and genomic competencies that inform the practice of all nurses functioning at the graduate level in nursing, summarizes the key documents and processes used to identify these competencies, and identifies the members of the Steering, Advisory and Consensus Panel committees involved--Provided by publisher. |
npj precision oncology impact factor: Central Nervous System Metastases Manmeet Ahluwalia, Philippe Metellus, Riccardo Soffietti, 2019-11-05 This book provides a comprehensive overview of brain metastases, from the molecular biology aspects to therapeutic management and perspectives. Due to the increasing incidence of these tumors and the urgent need to effectively control brain metastatic diseases in these patients, new therapeutic strategies have emerged in recent years. The volume discusses all these innovative approaches combined with new surgical techniques (fluorescence, functional mapping, integrated navigation), novel radiation therapy techniques (stereotactic radiosurgery) and new systemic treatment approaches such as targeted- and immunotherapy. These combination strategies represent a new therapeutic model in brain metastatic patients in which each medical practitioner (neurosurgeon, neurologist, medical oncologist, radiation oncologist) plays a pivotal role in defining the optimal treatment in a multidisciplinary approach. Written by recognized experts in the field, this book is a valuable tool for neurosurgeons, neuro-oncologists, neuroradiologists, medical oncologists, radiation oncologists, cognitive therapists, basic scientists and students working in the area of brain tumors. |
npj precision oncology impact factor: Multimodal Scene Understanding Michael Ying Yang, Bodo Rosenhahn, Vittorio Murino, 2019-07-16 Multimodal Scene Understanding: Algorithms, Applications and Deep Learning presents recent advances in multi-modal computing, with a focus on computer vision and photogrammetry. It provides the latest algorithms and applications that involve combining multiple sources of information and describes the role and approaches of multi-sensory data and multi-modal deep learning. The book is ideal for researchers from the fields of computer vision, remote sensing, robotics, and photogrammetry, thus helping foster interdisciplinary interaction and collaboration between these realms. Researchers collecting and analyzing multi-sensory data collections – for example, KITTI benchmark (stereo+laser) - from different platforms, such as autonomous vehicles, surveillance cameras, UAVs, planes and satellites will find this book to be very useful. - Contains state-of-the-art developments on multi-modal computing - Shines a focus on algorithms and applications - Presents novel deep learning topics on multi-sensor fusion and multi-modal deep learning |
npj precision oncology impact factor: Microbiome and Cancer Erle S. Robertson, 2019-02-20 This book ventures into a new and exciting area of discovery that directly ties our current knowledge of cancer to the discovery of microorganisms associated with different types of cancers. Recent studies demonstrate that microorganisms are directly linked to the establishment of cancers and that they can also contribute to the initiation, as well as persistence of, the cancers. Microbiome and Cancer covers the current knowledge of microbiome and its association with human cancers. It provides important reading for novices, senior undergraduates in cancer and microbiology, graduate students, junior investigators, residents, fellows and established investigators in the fields of cancer and microbiology. We cover areas related to known, broad concepts in microbiology and how they can relate to the ongoing discoveries of the micro-environment and the changes in the metabolic and physiologic states in that micro-environment, which are important for the ongoing nurturing and survival of the poly-microbial content that dictates activities in that micro-environment. We cover the interactions of microorganisms associated with gastric carcinomas, which are important for driving this particular cancer. Additional areas include oral cancers, skin cancers, ovarian cancers, breast cancers, nasopharyngeal cancers, lung cancers, mesotheliomas, Hodgkin’s and non-Hodgkin’s lymphomas, glioblastoma multiforme, hepatocellular carcinomas, as well as the inflammatory response related to the infectious agents in cancers. This book covers the metabolic changes that occur because of infection and their support for development of cancers, chronic infection and development of therapeutic strategies for detection and control of the infection. The field of microbiome research has exploded over the last five years, and we are now understanding more and more about the context in which microorganisms can contribute to the onset of cancers in humans. The field of microbiome research has demonstrated that the human body has specific biomes for tissues and that changes in these biomes at the specific organ sites can result in disease. These changes can result in dramatic differences in metabolic shifts that, together with genetic mutations, will produce the perfect niche for establishment of the particular infection programmes in that organ site. We are just beginning to understand what those changes are and how they influence the disease state. Overall, we hope to bring together the varying degrees of fluctuations in the microbiome at the major organ sites and how these changes affect the normal cellular processes because of dysregulation, leading to proliferation of the associated tissues. |
npj precision oncology impact factor: The Internet of Healthy Things Joseph C. Kvedar, 2015-10-23 This important book clearly explains how new smart devices and Internet-based technologies make it possible for healthcare providers and patients to work together to improve health in ways that are powerful and previously unimaginable--page xi, Foreword. |
npj precision oncology impact factor: The New Mobile Age Joseph C. Kvedar, 2017-10-17 Aging Baby Boomers want to grow old-and maintain their health-on their own terms. Digital technologies are creating a new kind of old, enabling individuals to remain vital, engaged and independent through their later years. But it has to be the right technology, designed for an aging population, not just what technologists and app developers think people want. Social robots, artificial intelligence, vocal biomarkers and facial decoding will analyze emotion, anticipate health problems, improve quality of life and enable better relationships with healthcare providers. Data can be used to better understand the 'soft science' of wellbeing and address the neglected crisis of caregiving. It's a business model but, more so, it's a new way of life. The New Mobile Age: How Technology Will Extend the Healthspan and Optimize the Lifespan explores the critical steps needed to achieve healthy longevity at a time when digital and connected health solutions are urgently needed to accommodate the aging of our population. Health tech innovations will not just improve healthcare for older adults, but will create a better and more responsive healthcare system for everyone. |
npj precision oncology impact factor: ICT for Intelligent Systems Jyoti Choudrie, |
npj precision oncology impact factor: Breast Imaging Christoph I. Lee, Constance D. Lehman, Lawrence W. Bassett, 2018 Breast Imaging presents a comprehensive review of the subject matter commonly encountered by practicing radiologists and radiology residents in training. This volume includes succinct overviews of breast cancer epidemiology, screening, staging, and treatment; overviews of all imaging modalities including mammography, tomosynthesis, ultrasound, and MRI; step-by-step approaches for image-guided breast interventions; and high-yield chapters organized by specific imaging finding seen on mammography, tomosynthesis, ultrasound, and MRI. Part of the Rotations in Radiology series, this book offers a guided approach to breast imaging interpretation and techniques, highlighting the nuances necessary to arrive at the best diagnosis and management. Each chapter contains a targeted discussion of an imaging finding which reviews the anatomy and physiology, distinguishing features, imaging techniques, differential diagnosis, clinical issues, key points, and further reading. Breast Imaging is a must-read for residents and practicing radiologists seeking a foundation for the essential knowledge base in breast imaging. |
npj precision oncology impact factor: Toward Precision Medicine National Research Council, Division on Earth and Life Studies, Board on Life Sciences, Committee on A Framework for Developing a New Taxonomy of Disease, 2012-01-16 Motivated by the explosion of molecular data on humans-particularly data associated with individual patients-and the sense that there are large, as-yet-untapped opportunities to use this data to improve health outcomes, Toward Precision Medicine explores the feasibility and need for a new taxonomy of human disease based on molecular biology and develops a potential framework for creating one. The book says that a new data network that integrates emerging research on the molecular makeup of diseases with clinical data on individual patients could drive the development of a more accurate classification of diseases and ultimately enhance diagnosis and treatment. The new taxonomy that emerges would define diseases by their underlying molecular causes and other factors in addition to their traditional physical signs and symptoms. The book adds that the new data network could also improve biomedical research by enabling scientists to access patients' information during treatment while still protecting their rights. This would allow the marriage of molecular research and clinical data at the point of care, as opposed to research information continuing to reside primarily in academia. Toward Precision Medicine notes that moving toward individualized medicine requires that researchers and health care providers have access to very large sets of health- and disease-related data linked to individual patients. These data are also critical for developing the information commons, the knowledge network of disease, and ultimately the new taxonomy. |
npj precision oncology impact factor: Advances in Radiation Oncology Jeffrey Y.C. Wong, Timothy E. Schultheiss, Eric H. Radany, 2017-04-20 This book concisely reviews important advances in radiation oncology, providing practicing radiation oncologists with a fundamental understanding of each topic and an appreciation of its significance for the future of radiation oncology. It explores in detail the impact of newer imaging modalities, such as multiparametric magnetic resonance imaging (MRI) and positron emission tomography (PET) using fluorodeoxyglucose (FDG) and other novel agents, which deliver improved visualization of the physiologic and phenotypic features of a given cancer, helping oncologists to provide more targeted radiotherapy and assess the response. Due consideration is also given to how advanced technologies for radiation therapy delivery have created new treatment options for patients with localized and metastatic disease, highlighting the increasingly important role of image-guided radiotherapy in treating systemic and oligometastatic disease. Further topics include the potential value of radiotherapy in enhancing immunotherapy thanks to the broader immune-stimulatory effects, how cancer stem cells and the tumor microenvironment influence response, and the application of mathematical and systems biology methods to radiotherapy. |
npj precision oncology impact factor: Drug Repurposing in Cancer Therapy Kenneth K.W. To, William C.S. Cho, 2020-07-29 Drug Repurposing in Cancer Therapy: Approaches and Applications provides comprehensive and updated information from experts in basic science research and clinical practice on how existing drugs can be repurposed for cancer treatment. The book summarizes successful stories that may assist researchers in the field to better design their studies for new repurposing projects. Sections discuss specific topics such as in silico prediction and high throughput screening of repurposed drugs, drug repurposing for overcoming chemoresistance and eradicating cancer stem cells, and clinical investigation on combination of repurposed drug and anticancer therapy. Cancer researchers, oncologists, pharmacologists and several members of biomedical field who are interested in learning more about the use of existing drugs for different purposes in cancer therapy will find this to be a valuable resource. - Presents a systematic and up-to-date collection of the research underpinning the various drug repurposing approaches for a quick, but in-depth understanding on current trends in drug repurposing research - Brings better understanding of the drug repurposing process in a holistic way, combining both basic and clinical sciences - Encompasses a collection of successful stories of drug repurposing for cancer therapy in different cancer types |
npj precision oncology impact factor: Diagnosing and Treating Adult Cancers and Associated Impairments National Academies Of Sciences Engineeri, National Academies of Sciences Engineering and Medicine, Health And Medicine Division, Board On Health Care Services, Committee on Diagnosing and Treating Adult Cancers, 2021-11-10 Cancer is the second leading cause of death among adults in the United States after heart disease. However, improvements in cancer treatment and earlier detection are leading to growing numbers of cancer survivors. As the number of cancer survivors grows, there is increased interest in how cancer and its treatments may affect a person's ability to work, whether the person has maintained employment throughout the treatment or is returning to work at a previous, current, or new place of employment. Cancer-related impairments and resulting functional limitations may or may not lead to disability as defined by the U.S. Social Security Administration (SSA), however, adults surviving cancer who are unable to work because of cancer-related impairments and functional limitations may apply for disability benefits from SSA. At the request of SSA, Diagnosing and Treating Adult Cancers and Associated Impairments provides background information on breast cancer, lung cancer, and selected other cancers to assist SSA in its review of the listing of impairments for disability assessments. This report addresses several specific topics, including determining the latest standards of care as well as new technologies for understanding disease processes, treatment modalities, and the effect of cancer on a person's health and functioning, in order to inform SSA's evaluation of disability claims for adults with cancer. |
npj precision oncology impact factor: Tumor Progression and Metastasis Ahmed Lasfar, Karine Cohen-Solal, 2020 |
npj precision oncology impact factor: The Role of DNA Repair Pathways in Resistance to Chemotherapy and Radiotherapy in Cancer José Díaz-Chávez, Rosa Maria Bermudez-Cruz, David Y. Lee, 2022-04-29 |